“The island is my orchestra,” says Brown in a BBC video, about his efforts to record waves crashing, birds twittering, and wind in the trees, which he then mixes in the studio with non-classical music and the sounds of others' type of tinnitus to form the soundscape.
This financial progress reportedly enables the company to initiate its planned redefinition of its business growth strategy, concentrating the scope of its activities as a medical technology innovator, specializing in the design, development, and production of its own suite of proprietary therapeutic and diagnostic medical devices.
A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.
A new study from England reviewed 6 trials with a total of 553 adult patients suffering from tinnitus and treated with masking therapy. They found that the masking therapy alone could not be found to be conclusively effective.